BioSpace News Archive

OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, today announced the first surgery in the United Kingdom utilizing the new Pediatric Nailing Platform | FEMUR (“PNP|FEMUR”).

– Applied DNA’s safeCircle™ Program Integrates with CLEARED4 Digital Platform for Online Health Safety Management and Reporting, Option Geared for Scaling of High-Volume Testing Clients –

- 100% rate of BMT and engraftment in patients receiving therapeutic dose of Iomab-B and lower rates of sepsis and sepsis related Grade ≥3 adverse events compared to patients receiving salvage therapies at 75% enrollment recently highlighted in oral presentations at ASH 2020 Annual Meeting - Independent Data Monitoring Committee recommends SIERRA continue as planned to full enrollment of 150 patients; trial is currently over 75% enrolled

Tempshield® Cryo-Protection®, the leader in certified products for the safe handling of cryogenic materials, is honored to announce that its Cryo-Gloves® have been instrumental in the first delivery of COVID-19 vaccines to essential workers in Maine.

The data are published in the Proceedings of the National Academy of Sciences Results suggest a potential therapeutic benefit for dapansutrile in patients with neuroinflammatory diseases, e.g., Alzheimer’s Disease

Capricor Therape u tics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class cell- and exosome-based therapeutics for the treatment and prevention of a variety of diseases and disorders, announced today that the independent Data and Safety Monitoring Board (DSMB) has completed its safety review for Capricor’s Phase II IN S PIR E study. The DSMB recommend

Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, announced today it has received guidance from the U.S Food & Drug Administration (“FDA”) regarding the impact of COVID-19 on its Phase III clinical tri

The following quote is attributed to Jeffrey Shuren M.D ., J.D., director of FDA’s Center for Devices and Radiological Health: “Providing women with access to safe medical devices to meet their health care needs is a top priority for the FDA. Today, we’ve taken two important steps on laparoscopic power morcellators as a

CYduct Diagnostics, Inc. (OTC PINK:SNDYD) is pleased to announce that FINRA has approved a change in the Company’s stock symbol trading on the OTC Markets. Effective tomorrow, December 30, 2020, the Company’s common shares will trade on the OTC Markets under the symbol “CYDX.”

Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that R.J. Smith, a seasoned leader in the orthopedic and medical device industry, has joined the company in the newly created role as Vice President of Customer Experience